Pharmaceutical
- 1186.926
- -10.368-0.87%
Stocks reaching the upper and lower limits in the first half of the trading session.
■Limit up <130A> Veritas In Silico <303A> visumo <4011> Headwaters ■Limit down <304A> Forcia <5241> Japan OA Research Institute *Includes temporary limit up and down (indication prices).
Rating [Securities company ratings]
Downgrade - Bearish Code Stock Name Securities Company Previous Change After------------------------------------------<4523> Eisai Marusan "Buy" "Hold"
List of stocks breaking through clouds (weekly chart) (part 1)
○ List of stocks that have surpassed the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Main Board <1332> Nissui 900 894.75 822 <1375> Yuki Country Maitake 1060 1018.75 1020 <1433> Bestella 1070 1011.25 1038 <1663> K&O Energy 3635 3483.75 3163 <1812> Kajima 2892 2823.
List of conversion stocks (Part 1) [Parabolic Signal Conversion Stocks]
○List of stocks undergoing Buy conversion in the market Code Stock Name Closing Price SAR Tokyo Main Board <1301> Kiyokyo 4115 3945 <1332> Nissui 900873 <1377> Sakata Seed 34703370 <1726> Br. HD 346330 <1802> Obayashi Corporation 21012025 <1808> Haseko Corporation 20491980 <1820> Nishimatsu Construction 52485066 <1887> Japan National.
December 30 [Today's Investment Strategy]
[Fisco Selected Stock] 【Material Stocks】 Polaris Holdings <3010> 172 yen (12/27) operates hotels such as "KOKO HOTELS". The performance forecast for the fiscal year ending March 2025 has been revised upwards. The operating profit is expected to be 2.2 billion yen (a 34.9% decrease from the previous period). This is an increase of about 16% from the previous forecast. The completion of the business integration with Minashia, which operates hotels and Restaurants, is the main reason for the revision. Additionally, the hotel business and others have exceeded initial expectations.
DNA, ETC [Stocks with Interest Viewed from Changes in Volume]
Closing price compared to the previous day Volume *<1483> iShares 2,896,811,217 *<162A> AI Select Daily Stock ETN 1,032,520,051,26 *<7044> Piarra 250,192,639,100 *<1474> One ETF Nikkei 26,190,695,954,7 *<2323> fonfun 884,118,107,200 *<1369> DIAM 225,405,108,501,5507 *<1625> Electronics Precision 391,106,701,466 *<234A>
Weakness, weighed down by factors such as falling US stocks [emerging markets individual stock strategy]
[Emerging Markets Individual Stock Strategy] Today's Emerging Markets are expected to experience a weak performance. In the U.S. stock market on the weekend of the 27th, the Dow Inc fell by 333.59 points (-0.77%) to 42,992.21 dollars, marking a downturn after six days. With limited participants as the year-end approaches, profit-taking selling occurred. In particular, technology stocks were sold off in anticipation of rebalancing for the new fiscal year, dragging down the overall market. The Emerging Markets today are likely to see a dominant selling trend. Given that major indices fell in the U.S. stock market last weekend and that Overseas market.
Pay attention to Marumae and WNI Weather, while Adastria and Okuwa may be sluggish.
Last weekend, on the 27th, in the US stock market, the Dow Jones Industrial Average fell by 333.59 points to 42,992.21, the Nasdaq Composite Index dropped by 298.33 points to 19,722.03, and the Chicago Nikkei 225 Futures decreased by 100 yen compared to the Osaka daytime price, settling at 40,130 yen. The exchange rate is 1 dollar = 157.80-90 yen. In today's Tokyo market, Marumae <6264> reported an operating profit of 0.444 billion yen in the first quarter, turning from a loss of 0.022 billion yen in the same period last year, while the operating profit for the first half increased by 32.8%, compared to 9.6% in the first quarter.
List of breakout stocks (Part 1) [Ichimoku Kinko Hyo - List of breakout stocks]
○ List of stocks above the clouds in the market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Main Board <1898> Seiki Tokyu 1554 1531.25 1533.5 <2002> Nisshin Flour G 1845.1810.75 1841.5 <2117> Welneo S 2229 2226.25 2212 <2127> Japan M&A 6536 48.25 644.5 <2331> ALSOK 1089 10
PRISM BioLab [Unlock Schedule]
■PRISM BioLab <206A> Estimated number of shares to be released: 7,669,400 shares (estimated) Release date: 2024/12/29 Target Shareholders : Estimated Shares Takehara Dai: 726,000 shares Nakashima Kiichiro: 1,872,000 shares Ohara Pharmaceutical Industry Co., Ltd.: 1,000,000 shares Takeda Hideki: 935,000 shares MediPal Holdings Co., Ltd.
DWTI, Architects SJ and others.
＜1447＞ Acquisition and cancellation of all remaining subscription rights of the 4th series (with exercise price adjustment clause) of SAAFD. ＜3557＞ Large exercise of the 9th subscription rights (with exercise price adjustment clause) of U&C from the 4th, number of shares delivered, 0.07 million, 2000 shares. ＜4576＞ Approval obtained in Thailand for the glaucoma and ocular hypertension treatment "Grau Alpha combination eye drops (domestic product name)" of DWTI. ＜4586＞ Termination of joint research contract with Medrec Fanpepp. ＜4881＞ Soleasia's downward revision, current period operations.
Adastria, 3Q operating profit decreased by 9.4% to 14.7 billion yen.
The third-quarter results for the fiscal year ending February 2025 announced by Adastria (2685) revealed that revenue increased by 8.3% year-on-year to 220 billion 89 million yen, while operating profit decreased by 9.4% to 14.7 billion 70 million yen. The sustained demand for outings and casual fashion consumption, along with effective product development aligned with trends, the nurturing of hit products, and successful promotions including TV commercials and point redemption, contributed to this performance. In Thailand, where business commenced in the second quarter, a second store opening led to significant growth.
Research drugs, ETC, continue to be ranked, with a licensing agreement related to Johnson & Johnson and STAT6 inhibitors.
Research pharmaceutical company <4521> has ranked (as of 14:32). It has seen significant continued growth. After the previous day's Trading ended, the company announced that it has signed a contract granting an exclusive license to Johnson & Johnson for the global development, manufacturing, and commercialization of the 'STAT6 Program' that is being developed as a next-generation oral treatment for type 2 inflammatory diseases (such as atopic dermatitis and asthma). It will receive a one-time contract payment of 30 million USD during the fiscal year ending March 2025.
Stocks that moved or were traded in the first half of the session.
* Makino Milling Machine <6135> 9250 - Nidec Corporation Sponsored ADR has announced an unsolicited tender offer. * DeNA <2432> 3060 +365 10-December period sees significant expansion in the Gaming business positively received. * Nomura Micro Science <6254> 2013 +168 the sentiment of a bottoming stock price may continue the trend of short covering. * Migaro HD <5535> 2600 +213 the growth expectations for the Facial Recognition platform business continue. * Kyowa Hakko Kirin <4521> 4497
December 27 [Today's Investment Strategy]
[Selected Stocks by Fisco] 【Material Stocks】 Kaken Pharmaceutical <4521> 4174 yen (12/26) Main products include the nail fungus treatment 'Klenafin' and the joint function improvement drug 'Alts'. The company announced the signing of a contract granting Johnson & Johnson exclusive rights for the development, manufacturing, and commercialization globally of the 'STAT6 Program', which is being developed as a next-generation oral treatment for type 2 inflammatory diseases (such as atopic dermatitis and asthma).
Steady, a sense of relief with the rise in long-term US Gold interest rates coming to a pause.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to show a solid performance. In the US stock market on the 26th, the Dow Inc rose by 28.77 dollars (+0.07%) to 43,325.80 dollars, marking a slight fifth consecutive gain. In the morning, selling was dominant as there was a surprising decrease in unemployment Insurance claims, leading to rising long-term interest rates. However, as the number of continuing unemployment Insurance beneficiaries reached a three-year high and the strong results of the 7-year bond auction caused interest rates to turn downward, buying became strong toward the end, and the Dow was...
Focus on DeNA and Kaken Pharmaceutical, while Oisix and Sankyo Tateyama may be sluggish.
In the US stock market on the 26th, the Dow Jones Industrial Average rose by $28.77 to 43,325.80, the Nasdaq Composite Index fell by 10.77 points to 20,020.36, and the Chicago Nikkei 225 Futures were up by 210 yen compared to Osaka daytime at 39,700 yen. The exchange rate was 1 dollar = 158.00-10 yen. In today's Tokyo market, Kusuri no Aoki <3549> saw an increase in operating profit of 85.5%, expanding from 10.2% growth in the first quarter, and the performance of its gaming business for the fiscal year ending in March 2025 is expected to see an increase in both revenue and profit compared to the previous period.
Rena Science, Genie and others.
The complete acquisition and cancellation of the remaining 27th subscription rights of Shannon (with exercise price adjustment clause) and the issuance of the 23rd subscription rights (with exercise price adjustment clause) (number of potential Stocks 1.37 million 4,600 stocks, raised approximately 0.143 billion yen) issuance of the 24th subscription rights (with exercise price adjustment clause) (number of potential Stocks 6 million stocks, raised approximately 0.567 billion yen) acquisition of BASEE store's Stocks (4304) and making it a subsidiary, and the remaining 15th and 18th subscription rights of Kids Bio (4584).
With limited participants, export stocks are leading the market.
The Nikkei average continued to rise significantly, closing at 39,568.06 yen, up 437.63 yen (with an estimated Volume of 1.9 billion 60 million shares). With European and American markets closed, market participants were limited and the day started slightly lower. However, as the yen temporarily weakened to around 157 yen per dollar, export stocks such as Automobiles were actively bought, and the Nikkei average even extended its gains to 39,592.28 yen towards the end of the afternoon session. Additionally, as the final trading day for year-end settlements approached, individual tax-saving sell-offs also peaked.
Afternoon session [Active stocks and traded stocks]
*Aresti <5852> 605 +18 Introduced a shareholder benefit program. *Nihon Hume <5262> 1395 +46 Changed and expanded the shareholder benefit program. *Nifco <7988> 3868 +124 Announced a Share Buyback with a limit of 0.60% of the issued Stocks. *Towns <197A> 591 +52 Reached a basic agreement on a trade contract with Roche Diagnostics. *Stella Chemifa <4109> 4250 +170 Financial Estimates for the fiscal year ending March 2025 and mid-term management plan numbers.